2007
DOI: 10.1093/jac/dkm245
|View full text |Cite
|
Sign up to set email alerts
|

Differential cytotoxicity of phospholipid analogues to pathogenic Acanthamoeba species and mammalian cells

Abstract: Objectives: Previous studies have reported the ability of several phospholipid analogues to successfully inhibit the growth of Acanthamoeba species in vitro. This study tests further phospholipid analogues, either as free drug or in liposomal formulations, and unlike previous studies, examines their comparative toxicities to mammalian cells. Methods:The relative cytotoxic activities of the phospholipid derivatives hexadecyl-PC, octadecyl-PC, elaidyl-PC, erucyl-PC and edelfosine, against Acanthamoeba castellani… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…Finally, since synthetic PC analogues were recently suggested as promising drugs against Acanthamoeba species [7], [33], the results obtained may help to find more effective antimicrobials to treat Acanthamoeba infections. The goal of our future studies is to assess the biological significance of these fatty acids and their sensitivity/resistance to antiprotozoal agents.…”
Section: Discussionmentioning
confidence: 98%
“…Finally, since synthetic PC analogues were recently suggested as promising drugs against Acanthamoeba species [7], [33], the results obtained may help to find more effective antimicrobials to treat Acanthamoeba infections. The goal of our future studies is to assess the biological significance of these fatty acids and their sensitivity/resistance to antiprotozoal agents.…”
Section: Discussionmentioning
confidence: 98%
“…While a wide range of antiparasitic, antimicrobial, and other pharmacologic agents has been tested against Acanthamoeba, these agents have shown limited activity and reports of successful treatment have been few (18)(19)(20)(21)(22). The current drugs of choice in treating Acanthamoeba keratitis are two biguanides and two diamidines.…”
Section: Discussionmentioning
confidence: 99%
“…The combination of different administration routes has also provided positive outcomes, for example topical and systemic administration using topical chlorhexidine 0.06% and propamidine isetionate 0.1% and the zwitterionic alkylphosphocholine (APC) called miltefosine 25,26 . APCs are also effective against kinetoplastids (Trypanosoma and Leishmania), anaerobic parasites (Trichomonas and Entamoeba) and other amoebae (Naegleria, as well as Acanthamoeba) trophozoites and cysts, but can induce encystation in Acanthamoeba [27][28][29][30][31][32] . Structure-activities studies in Leishmania 33 and Acanthamoeba 29 have demostrated that changes in the physical strucure of the APC can increase efficacy.…”
mentioning
confidence: 99%